The Role of Hypoxia-Inducible Factor 1 Alpha in Acute-on-Chronic Liver Failure - (2024)

Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trial - (2023)

Operating under pressure: Is there a place for preoperative TIPS? - (2024)

Stage of fibrosis is not a predictive determinant of weight loss in patients undergoing bariatric surgery - (2024)

Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) and the role of biomarkers - (2024)

Review: Opportunities and barriers for omics-based biomarker discovery in steatotic liver diseases - (2024)

Modeling microbiota-associated human diseases: from minimal models to complex systems - (2022)

Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy - (2023)

Cardiometabolic health, diet and the gut microbiome: a meta-omics perspective - (2023)

Questioning the fetal microbiome illustrates pitfalls of low-biomass microbial studies - (2023)